Crystallization of antiangiogenic Kringle V derived from human apolipoprotein A: Crystallization applied to purification and formulation

Bioscience, Biotechnology and Biochemistry

Volumn 70, Issue 4, 2006, Pages 916-925

  Kang, Kwan Yub ^a,b   Park, Jung Hwan ^b   Lim, In Hwan ^b   Kim, Sung Geun ^b   Park, See Hyoung ^b   Kim, Won Kyung ^b   Hong, Jeong Woon ^b   You, Hyun Kyung ^b   Jung, Kyung Hwan ^b   Kim, Chan Wha ^a  

^a Korea University   (South Korea)

^b Mogam Biotechnology Research Institute   (South Korea)

Author keywords

Antiangiogenic polypeptide; Apolipoprotein A; Crystal; Formulation; Kringle

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; CRYSTALLIZATION; CRYSTALS; MOLECULAR WEIGHT; PURIFICATION;

ANTIANGIOGENIC POLYPEPTIDE; APOLIPOPROTEIN A; FORMULATION; KRINGLE;

PROTEINS;

ANGIOGENESIS INHIBITOR; APOLIPOPROTEIN A;

ARTICLE; CELL CULTURE; CELL MOTION; CHEMISTRY; CRYSTALLIZATION; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; ISOLATION AND PURIFICATION; KRINGLE DOMAIN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; MOLECULAR WEIGHT; PH; SOLUBILITY; UMBILICAL CORD;

ANGIOGENESIS INHIBITORS; APOLIPOPROTEINS A; CELL MOVEMENT; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; CRYSTALLIZATION; ENDOTHELIAL CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; KRINGLES; MASS SPECTROMETRY; MOLECULAR WEIGHT; SOLUBILITY; UMBILICAL CORD;

PICHIA PASTORIS;

EID: 33646142525     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.70.916     Document Type: Article

References (31)

1. Ponting, C. P., Marshall, J. M., and Cederholm-Williams, S. A., Plasminogen: a structural review. Blood Coagul. Fibrinolysis, 3, 605-614 (1992).
2. Dominguez, M., Rojas, G., Loyau, S., Bazurco, M., Sorell, L., and Angles-Cano, E., Kringles of the plasminogen-prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a). Biochim. Biophys. Acta, 1548, 72-80 (2001).
3. Li, X., Bokman, A. M., Llinas, M., Smith, R. A., and Dobson, C. M., Solution structure of the kringle domain from urokinase-type plasminogen activator. J. Mol. Biol., 235, 1548-1559 (1994).
4. Kuba, K., Matsumoto, K., Date, K., Shimura, H., Tanaka, M., and Nakamura, T., HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res., 60, 6737-6743 (2000).
5. Cao, Y., Cao, R., and Veitonmaki, N., Kringle structures and antiangiogenesis. Curr. Med. Chem. Anti-Canc. Agents, 2, 667-681 (2002).
6. Folkman, J., Role of angiogenesis in tumor growth and metastasis. Semin. Oncol., 29, 15-18 (2002).
7. Schulter, V., Koolwijk, P., Peters, E., Frank, S., Hrzenjak, A., Graier, W. F., van Hinsbergh, V. W., and Kostner, G. M., Impact of apolipoprotein (a) on in vitro angiogenesis. Arterioscler. Thromb. Vasc. Biol., 21, 433-438 (2001).
8. Adam, P. D., Pramila, A., Roseanne, B., Jesus, V. S., Carolyn, S., Edward, G., and Walter, J. C., Phase 1 trial result and preclinical studies of recombinant human Angiostatin (rhAngiostatin) and experimental radiation therapy (EBRT), Annual Meeting of American Society of Clinical Oncology (ASCO) Orlando, Florida (2002).
9. Beerepoot, L. V., Witteveen, E. O., Groenewegen, G., Fogler, W. E., Sim, B. K., Sidor, C., Zonnenberg, B. A., Schramel, F., Gebbink, M. F., and Voest, E. E., Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study. Clin. Cancer Res., 9, 4025-4033 (2003).
10. Kim, J. S., Chang, J. H., Yu, H. K., Ahn, J.-H., Yum, J. S., Lee, S. K., Jung, K. H., Park, D. H., Yoon, Y., Byun, S. M., and Chung, S. I., Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein (a). J. Biol. Chem., 278, 29000-29008 (2003).
11. Kim, J. S., Yu, H. K., Ahn, J. H., Lee, H. J., Hong, S. W., Jung, K. H., Chang, S. I., Hong, Y. K., Joe, Y. A., Byun, S. M., Lee, S. K., Chung, S. I., and Yoon, Y., Human apolipoprotein (a) kringle V inhibits angiogenesis in vitro and in vivo by interfering with the activation of focal adhesion kinases. Biochem. Biophys. Res. Commun., 313, 534-540 (2004).
12. Cannata, J. J. B., Phosphoenolpyruvate carboxykinase from bakers' yeast: isolation of the enzyme and study of its physical properties. J. Biol. Chem., 245, 792-798 (1970).
13. Choi, S. H., Kwon, J. H., and Kim, C. W., Microencapsulation of insulin microdrytlas. Biosci. Biotechnol. Biochem., 68, 749-752 (2004).
14. Kwon, J. H., and Kim, C. W., A novel insulin microcrystal preparation using a seed zone method. J. Crystal Growth, 268, 536-543 (2004).
15. Ducrux, A., and Giegé, R., Methods of crystallization. In "Crystallization of Nucleic Acid and Proteins, a Practical Approach," eds. Ducrux, A., and Giegé, R., Oxford University Press, New York, pp. 73-98 (1992).
16. Yang, M. X., Shenoy, B., Disttler, M., Patel, R., McGrath, M., Pechenov, S., and Margolin, A. L., Crystalline monoclonal antibodies for subcutaneous delivery. Proc. Natl. Acad. Sci. USA, 100, 6934-6939 (2003).
17. Kwon, J. H., Lee, B. H., Lee, J. J., and Kim, C. W., Insulin microcrystal suspension as a long-acting formulation for pulmonary delivery. Eur. J. Pharm. Sci., 22, 107-116 (2004).
18. Lee, M. J., Kwon, J. H., Shin, J. S., and Kim, C. W., Microcrystallization of α-lactalbumin. J. Crystal Growth, in press.
19. Zhu, M., Cheng, J., and Hua, Z. C., Expression of kringle 5 domain of human plasminogen in Pichia pastoris. Prep. Biochem. Biotechnol., 33, 269-281 (2003).
20. Shepard, S. R., Boucher, R., Johnston, J., Boerner, R., Koch, G., Madsen, J. W., Grella, D., Sim, B. K., and Schrimsher, J. L., Large-scale purification of recombinant human angiostatin. Protein Expr. Purif., 20, 216-227 (2000).
21. Shepard, S. R., Boyd, G. A., and Schrimsher, J. L., Routine manufacture of recombinant proteins using expanded bed adsorption chromatography. Bioseparation, 10, 51-56 (2001).
22. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C., Measurement of protein using bicinchoninic acid. Anal. Biochem., 150, 76-85 (1985).
23. Jen, A., Madorin, K., Vosbeck, K., Arvinte, T., and Merkle, H. P., Transforming growth factor beta-3 crystals as reservoirs for slow release of active TGF beta-3. J. Control. Release, 78, 25-34 (2002).
24. Mark, L. B., Muppalla, S., Allen, H. P., David, S. M., Ronald, E. C., David, B. F., Amy, L. C., Lynnie, I., and Sharon, R. M., Hybrid insulin cocrystals for controlled release. Nat. Biotechnol., 20, 800-804 (2002).
25. Mochizuki, S., Hamato, N., Hirose, M., Miyano, K., Ohtani, W., Kameyama, S., Kuwae, S., Tokuyama, T., and Ohi, H., Expression and characterization of recombinant human antithrombin III in Pichia pastoris. Protein Expr. Purif., 23, 55-65 (2001).
26. Murasugi, A., and Tohma-Aiba, Y., Characterization of partially truncated human midkine expressed in Pichia pastoris. Biosci. Biotechnol. Biochem., 66, 1295-1300 (2002).
27. Murasugi, A., and Tohma-Aiba, Y., Production of native recombinant human midkine in the yeast, Pichia pastoris. Protein Expr. Purif., 27, 244-252 (2003).
28. Duman, J. G., Miele, R. G., Liang, H., Grella, D. K., Sim, K. L., Castellino, F. J., and Bretthauer, R. K., O-Mannosylation of Pichia pastoris cellular and recombinant proteins. Biotechnol. Appl. Biochem., 28, 39-45 (1998).
29. Asami, Y., Nagano, H., Ikematsu, S., and Murasugi, A., An approach to the removal of yeast specific O-linked oligo-mannoses from human midkine expressed in Pichia pastoris using site-specific mutagenesis. J. Biochem. (Tokyo), 128, 823-826 (2000).
30. Letourneur, O., Gervasi, G., Gaia, S., Pages, J., Watelet, B., and Jolivet, M., Characterization of Toxoplasma gondii surface antigen 1 (SAG1) secreted from Pichia pastoris: evidence of hyper O-glycosylation. Biotechnol. Appl. Biochem., 33 (Pt. 1), 35-45 (2001).
31. Gale, R., Protein crystals. In "Crystallography Made Crystal Clear," ed. Gale, R., Academic Press, London, pp. 29-44 (2000).